Stephen Jurvetson Overview

  • Investor Type
  • Angel

  • Investments
  • 7

  • Portfolio
  • 2

  • Exits
  • 4


Stephen Jurvetson General Information


Mr. Stephen Jurvetson is a Co-Founder of Future Ventures. He served as an Advisor at Cleartrace and Deep Genomics. He is an Investor of Upside Foods. He serves as a Board Member at SpaceX & ZaiNar. He also serves as a Board Observer at Zyphra. He served as a Board Member & Member of Audit Committee & Disclosure Control Committee at Tesla. He serves as a Board Observer at Cambrian. He served as a Board Member at Planet, Flux, and Synthetic Genomics. He is an Angel Investor. He also co-founded and served as its Partner, Venture Team at Draper Fisher Jurvetson. He was the founding VC investor in Hotmail, Interwoven (IWOV), Kana (KANA), and NeoPhotonics (NPTN). He also led DFJ's investments in other companies that were acquired for $12 billion in aggregate. Previously, he was an R&D Engineer at Hewlett-Packard, where seven of his communications chip designs were fabricated. His prior technical experience also includes programming, materials science research, and computer design at HP's PC Division, the Center for Materials Research, and Mostek. He has also worked in product marketing at Apple and NeXT Software. He served as a Board Member at eSionic. As a consultant with Bain & Company, he developed executive marketing, sales, engineering, and business strategies for a wide range of companies in the software, networking, and semiconductor industries, He served as Board Observer at Genomatica.

Business Details

Primary Investor Type
Angel (individual)
Corporate Office
  • 465 First Street
  • Los Altos, CA 94022
  • United States

Stephen Jurvetson Investments (7)

Company Name Deal Date Deal Type Deal Size Industry Company Stage Lead Partner
Superplum 21-May-2021 Seed Round 00.000 Logistics Generating Revenue 0000000 000000000
Sensei Biotherapeutics 11-Jan-2021 00000 00000 0000 Drug Discovery Clinical Trials - Phase 1
ATAI Life Sciences 23-Nov-2020 00000 00000 00000 Drug Discovery Generating Revenue/Not Profitable 0000000 000000000
nCent 01-Jul-2018 0000 00000 0000 Media and Information Services (B2B) Generating Revenue 0000000 000000000
PurePlay 03-Jan-2007 00000 00000 00.000 Casinos and Gaming Out of Business
Longitude Systems 13-Nov-2001 Early Stage VC 0000 Communication Software Generating Revenue 0000000 000000000
Superplum Angel (individual) 000 Logistics Generating Revenue 0000000 000000000

Stephen Jurvetson Exits (4)

Company Name Exit Date Exit Type Exit Size
ATAI Life Sciences 18-Jun-2021 IPO 00000
Sensei Biotherapeutics 04-Feb-2021 000 00000
PurePlay 01-Oct-2018 Out of Business
Longitude Systems 27-Nov-2001 Merger/Acquisition

Stephen Jurvetson Investments by Industry, Year, and Region

Investments by Industry

Investments by Year

Investments by Region

PitchBook’s data visualizations quickly surface an investor’s historical investments—showing a breakdown of activity by industry, year and region.

Stephen Jurvetson Team (1)

Name Title Deals Funds Boards Office
Stephen Jurvetson Angel Investor 00 0 0 Los Altos, CA

Stephen Jurvetson Co-Investors (38)

Name With Exits Lead Partner Series Industry
Apeiron Investment Group 2 0 Series chart Industry bar
Catalio Capital Management 0 0 Series chart Industry bar
Future Ventures (San Francisco) 0 0 Series chart Industry bar
Korify Capital 0 0 Series chart Industry bar
Pura Vida Investments 0 0 Series chart Industry bar

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »